Y-Mabs Therapeutics (YMAB) Free Cash Flow (2018 - 2025)
Y-Mabs Therapeutics (YMAB) free cash flow from Sep 30, 2018 to Jun 30, 2025. The TTM Y-Mabs Therapeutics (YMAB) free cash flow is -$18M. You can adjust inflation or export chart.
Annual Free Cash Flow
Quarterly Free Cash Flow
Y-Mabs Therapeutics (YMAB) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +42.68% |
| 3 Years TTM | -43.66% |
| 5 Years TTM | -28.69% |
| All Time TTM | -19.72% |
Annual Free Cash Flow change of Y-Mabs Therapeutics (YMAB)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$5.39M | -65.69% |
| 2024 | -$16M | -42.31% |
| 2023 | -$27M | -64.13% |
| 2022 | -$76M | -26.46% |
| 2021 | -$103M | +12.94% |
| 2020 | -$91M | +21.12% |
| 2019 | -$75M | +82.01% |
| 2018 | -$41M | N/A |